IP Verse

Teva Pharmaceuticals USA, Inc. et al. vs Merck Sharp & Dohme Corp. et al.

The detailed information for PTAB case with proceeding number IPR2020-01045 filed by Teva Pharmaceuticals USA, Inc. et al. against Merck Sharp & Dohme Corp. et al. on Jun 10, 2020. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2020-01045
Filing Date: Jun 10, 2020
Petitioner: Teva Pharmaceuticals USA, Inc. et al.
Respondent: Merck Sharp & Dohme Corp. et al.
Status: Terminated-Settled
Respondent Application Number: 10874992
Respondent Tech Center: 1600
Respondent Patent Number: 7326708
Institution Decision Date: Sep 1, 2020
Termination Date: Dec 8, 2020

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Termination Decision Document	Dec 8, 2020	PAPER	BOARD
Joint Motion to Terminate IPR Pursuant to 35 U.S.C. s 317	Nov 24, 2020	PAPER	PETITIONER
Exhibit 1023	Nov 24, 2020	EXHIBIT	PETITIONER
Joint Motion to Treat Settlement Agreements (EX. 1023) as Business Confidential Information Pursuant to 35 U.S.C. s 317(b) and 37 C.F.R. s 42.74(c) and to Keep Separate	Nov 24, 2020	PAPER	PETITIONER
Petitioners' Updated Exhibit List	Nov 24, 2020	PAPER	PETITIONER
Decision - Granting Institution of Inter Partes Review; Granting Motion for Joinder	Sep 1, 2020	PAPER	BOARD
Petitioners' Updated Mandatory Notices	Aug 20, 2020	PAPER	PETITIONER
Teva Pharmaceuticals USA, Inc.'s Updated Power of Attorney	Aug 20, 2020	PAPER	PETITIONER
Watson Laboratories, Inc.'s Updated Power of Attorney	Aug 20, 2020	PAPER	PETITIONER
Patent Owner's Preliminary Response	Aug 14, 2020	PAPER	PATENT OWNER
Watson Complaint	Aug 14, 2020	EXHIBIT	PATENT OWNER
Patent Owner's Amended Exhibit List	Aug 14, 2020	PAPER	PATENT OWNER
Granting Petitioner's Motion for Pro Hac Vice Admission of Emily L. Rapalino	Aug 7, 2020	PAPER	BOARD
Petitioners' Joint Reply in Support of Motions for Joinder under 37 C.F.R. Secs. 42.22 AND 42.122(b)	Jul 29, 2020	PAPER	PETITIONER
Exhibit 1019	Jul 29, 2020	EXHIBIT	PETITIONER
Exhibit 1020	Jul 29, 2020	EXHIBIT	PETITIONER
Exhibit 1021	Jul 29, 2020	EXHIBIT	PETITIONER
Exhibit 1022	Jul 29, 2020	EXHIBIT	PETITIONER
Petitioners' Updated Exhibit List	Jul 29, 2020	PAPER	PETITIONER
Petitioners' Updated Exhibit List	Jul 27, 2020	PAPER	PETITIONER
Petitioners' Motion for Pro Hac Vice Admission of Emily L. Rapalino Under 37 C.F.R. s. 42.10(c)	Jul 27, 2020	PAPER	PETITIONER
Declaration of Emily L. Rapalino in Support of Petitioners' Motion for Pro Hac Vice Admission Under 37 C.F.R. s. 42.10(c)	Jul 27, 2020	EXHIBIT	PETITIONER
Patent Owner's Opposition to Motion for Joinder	Jul 9, 2020	PAPER	PATENT OWNER
EX2027 - 2020.06.29 Email regarding Mylan Opposition to Schedule Change	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2028 - 2020.06.26 Letter to Joinder Petitioners	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2032 - U.S. Patent No. 8,309,724	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2033 - WO 2013001457	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2035 - 2020.07.02 Email regarding Chorghade Deposition Date	Jul 9, 2020	EXHIBIT	PATENT OWNER
Patent Owner's Exhibit List	Jul 9, 2020	PAPER	PATENT OWNER
EX2029 - 2020.07.01 Email from Joinder Petitioners	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2030 - Excerpt of January 29, 2015 Trial Transcript with Dr. Chyall¿¿¿s Testimony	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2031 - Excerpt of Dr. Chyall's third declaration	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2034 - Sun Pharm Indus. Ltd. Corporate Action Report	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2036 - 2020.07.02 Email from Mylan Reserving Rights	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2037 - 2020.07.02 Email from Merck to Joinder Petitioners	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2038 - 2020.07.07 Email from Joinder Petitioners	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2039 - Teva Complaint	Jul 9, 2020	EXHIBIT	PATENT OWNER
EX2040 - Sun Complaint	Jul 9, 2020	EXHIBIT	PATENT OWNER
Patent Owner's Power of Attorney	Jul 1, 2020	PAPER	PATENT OWNER
Patent Owner's Mandatory Notices	Jul 1, 2020	PAPER	PATENT OWNER
Ex. 3001	Jun 24, 2020	EXHIBIT	BOARD
Notice of Accord Filing Date	Jun 22, 2020	PAPER	BOARD
ORDER Conduct of the Proceeding	Jun 18, 2020	PAPER	BOARD
Watson Laboratories, Inc.'s Power of Attorney	Jun 10, 2020	PAPER	PETITIONER
Exhibit 1004	Jun 10, 2020	EXHIBIT	PETITIONER
Teva Pharmaceuticals USA, Inc.'s Power of Attorney	Jun 10, 2020	PAPER	PETITIONER
Exhibit 1001	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1002	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1003	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1007	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1008	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1009	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1011	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1013	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1014	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1005	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1006	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1010	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1012	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1015	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1016	Jun 10, 2020	EXHIBIT	PETITIONER
Exhibit 1017	Jun 10, 2020	EXHIBIT	PETITIONER
Petition for Inter Partes Review of U.S. Patent No. 7,326,708 Under 35 U.S.C. sec. 311-319 and 37 C.F.R. sec. 42.1-.80, 42.100-.123	Jun 10, 2020	PAPER	PETITIONER
Petitioner's Motion for Joinder Under 37 C.F.R. sec. 42.22 and 42.122(b)	Jun 10, 2020	PAPER	PETITIONER